X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1496) 1496
Publication (176) 176
Book Review (71) 71
Newsletter (39) 39
Magazine Article (31) 31
Book Chapter (7) 7
Trade Publication Article (7) 7
Book / eBook (5) 5
Web Resource (5) 5
Conference Proceeding (4) 4
Dissertation (4) 4
Newspaper Article (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oxycodone (999) 999
humans (877) 877
index medicus (757) 757
pharmacology & pharmacy (700) 700
male (577) 577
morphine (458) 458
pain (457) 457
female (446) 446
opioids (385) 385
adult (343) 343
oxycodone - administration & dosage (331) 331
analgesics, opioid - administration & dosage (311) 311
middle aged (298) 298
analgesics, opioid - therapeutic use (280) 280
analgesics (278) 278
pain - drug therapy (271) 271
animals (254) 254
narcotics (254) 254
analgesics, opioid - adverse effects (244) 244
oxycodone - pharmacology (242) 242
oxycodone - therapeutic use (241) 241
pharmacokinetics (241) 241
oxycodone - adverse effects (215) 215
analgesics, opioid - pharmacology (212) 212
care and treatment (206) 206
double-blind (202) 202
aged (198) 198
double-blind method (175) 175
analgesia (167) 167
opioid (162) 162
cancer pain (158) 158
management (156) 156
dose-response relationship, drug (155) 155
oxycodone - pharmacokinetics (154) 154
pharmacology (152) 152
rats (152) 152
neurosciences (147) 147
analgesics, opioid - pharmacokinetics (146) 146
controlled-release oxycodone (145) 145
chronic pain (142) 142
analysis (141) 141
central nervous system depressants (140) 140
efficacy (136) 136
young adult (132) 132
pain management (127) 127
delayed-action preparations (126) 126
pain measurement (126) 126
anesthesiology (124) 124
pharmacology/toxicology (123) 123
fentanyl (122) 122
research (122) 122
drug abuse (118) 118
internal medicine (118) 118
medicine & public health (117) 117
clinical neurology (111) 111
drugs (111) 111
cancer (109) 109
cross-over studies (107) 107
dosage and administration (107) 107
mice (106) 106
neuropathic pain (103) 103
drug combinations (101) 101
adolescent (100) 100
article (97) 97
safety (95) 95
abuse (93) 93
treatment outcome (93) 93
united-states (92) 92
psychiatry (90) 90
pharmacodynamics (88) 88
administration, oral (87) 87
drug therapy (87) 87
codeine (86) 86
medicine, general & internal (86) 86
naloxone (86) 86
drug dosages (84) 84
pain - etiology (83) 83
morphine - pharmacology (82) 82
drug interactions (80) 80
constipation (79) 79
aged, 80 and over (77) 77
morphine - administration & dosage (77) 77
tramadol (76) 76
rats, sprague-dawley (75) 75
toxicology (75) 75
methadone (73) 73
morphine - therapeutic use (73) 73
pain, postoperative - drug therapy (73) 73
pharmacotherapy (73) 73
oral oxycodone (70) 70
time factors (70) 70
chronic noncancer pain (69) 69
chronic pain - drug therapy (68) 68
postoperative pain (68) 68
metabolism (67) 67
clinical trials (66) 66
buprenorphine (65) 65
patients (64) 64
analgesics - therapeutic use (62) 62
hydrocodone (62) 62
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1559) 1559
Japanese (27) 27
French (9) 9
German (6) 6
Chinese (2) 2
Polish (2) 2
Russian (2) 2
Spanish (2) 2
Czech (1) 1
Finnish (1) 1
Italian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Clinical Pharmacology, ISSN 0306-5251, 10/2017, Volume 83, Issue 10, pp. 2148 - 2162
Aims Aprepitant and fosaprepitant, commonly used for the prevention of chemotherapy‐induced nausea and vomiting, alter cytochrome P450 activity. This... 
aprepitant | drug–drug interactions | fosaprepitant | METHYLENE-BLUE | CHEMOTHERAPY-INDUCED NAUSEA | SITE ADVERSE EVENTS | CYTOCHROME-P450 3A4 | IFOSFAMIDE | drug-drug interactions | CANCER-PATIENTS | CONCISE GUIDE | PHARMACOKINETICS | PHARMACOLOGY & PHARMACY | INDUCED NEUROTOXICITY | RECEPTOR ANTAGONIST APREPITANT | Cytochrome P-450 CYP3A Inhibitors - pharmacology | Nausea - chemically induced | Humans | Antineoplastic Agents - therapeutic use | Drug Interactions | Cytochrome P-450 CYP2C9 Inducers - pharmacology | Antiemetics - therapeutic use | Antineoplastic Agents - pharmacology | Vomiting - prevention & control | Morpholines - therapeutic use | Quetiapine Fumarate - pharmacology | Aprepitant | Oxycodone - therapeutic use | Oxycodone - pharmacology | Injection Site Reaction - etiology | Serotonin Uptake Inhibitors - therapeutic use | Morpholines - pharmacology | Quetiapine Fumarate - therapeutic use | Nausea - prevention & control | Vomiting - chemically induced | Ethanol - pharmacology | Serotonin and Noradrenaline Reuptake Inhibitors - pharmacology | Cytochrome P-450 CYP2C9 Inducers - therapeutic use | Serotonin and Noradrenaline Reuptake Inhibitors - therapeutic use | Cytochrome P-450 CYP3A Inhibitors - therapeutic use | Antiemetics - pharmacology | Complications and side effects | Anthracyclines | Chemotherapy | Corticosteroids | Gastrointestinal agents | Drug interactions | Nausea | Cancer | Index Medicus | Systematic Review and Meta–Analysis
Journal Article
British Journal of Anaesthesia, ISSN 0007-0912, 06/2019, Volume 122, Issue 6, pp. e136 - e145
Journal Article
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 1/2011, Volume 67, Issue 1, pp. 63 - 71
Journal Article
Neuropharmacology, ISSN 0028-3908, 10/2017, Volume 125, pp. 231 - 242
Grip strength deficit is a measure of pain-induced functional disability in rheumatic disease. We tested whether this parameter and tactile allodynia, the... 
Animal model | Analgesia | Grip strength | Periarticular inflammation | Joint pain | Functional disability | ANTAGONIST | BEHAVIOR | TRPV1 | NEUROSCIENCES | RAT MODEL | ADJUVANT | PATHOGENESIS | ARTHRITIS PATIENTS | DISABILITY | NEURONS | PHARMACOLOGY & PHARMACY | OSTEOARTHRITIS | Analgesics - pharmacology | Inflammation - pathology | Arthritis - physiopathology | Rheumatic Diseases - drug therapy | Tramadol - pharmacology | Arthritis - diagnosis | Tarsus, Animal | Touch | Hyperalgesia - pathology | TRPV Cation Channels - metabolism | Acetaminophen - pharmacology | Inflammation - drug therapy | TRPV Cation Channels - antagonists & inhibitors | Female | Inflammation - diagnosis | Hyperalgesia - diagnosis | Hand Strength | Nociceptors - pathology | Rheumatic Diseases - pathology | Disease Models, Animal | Diterpenes - pharmacology | Ibuprofen - pharmacology | Oxycodone - pharmacology | Arthritis - pathology | Celecoxib - pharmacology | Rheumatic Diseases - diagnosis | Freund's Adjuvant | Hyperalgesia - physiopathology | Rheumatic Diseases - physiopathology | Pain Measurement - methods | Animals | Hyperalgesia - drug therapy | Ruthenium Red - pharmacology | Arthritis - drug therapy | Muscle Strength - drug effects | Nociceptors - metabolism | Nociceptors - drug effects | Inflammation - physiopathology | Medical tests | Inflammation | Neurophysiology | Drug discovery | Analysis
Journal Article